NASDAQ:CSBR
Champions Oncology, Inc.
- Stock
Last Close
4.70
17/05 20:00
Market Cap
85.03M
Beta: 0.87
Volume Today
2.73K
Avg: 10.77K
PE Ratio
−8.40
PFCF: −16.74
Apr '14 | Apr '15 | Apr '16 | Apr '17 | Apr '18 | Apr '19 | Apr '20 | Apr '21 | Apr '22 | Apr '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 11.55M - | 8.86M 23.26% | 11.18M 26.16% | 15.41M 37.82% | 20.24M 31.34% | 27.07M 33.72% | 32.12M 18.68% | 41.04M 27.76% | 49.11M 19.66% | 53.87M 9.69% | |
cost of revenue | 6.26M - | 7.63M 21.87% | 8.69M 13.80% | 9.70M 11.71% | 10.55M 8.76% | 14.27M 35.17% | 16.88M 18.35% | 21.47M 27.20% | 23.63M 10.05% | 29.53M 24.97% | |
gross profit | 5.29M - | 1.23M 76.74% | 2.50M 102.93% | 5.71M 128.69% | 9.69M 69.73% | 12.80M 32.14% | 15.24M 19.05% | 19.57M 28.38% | 25.48M 30.21% | 24.34M 4.47% | |
selling and marketing expenses | 3.15M - | 4.28M 35.75% | 3.44M 19.57% | 3.26M 5.34% | 2.57M 21.19% | 3.06M 18.91% | 4.24M 38.81% | 5.52M 30.13% | 6.38M 15.56% | 7.00M 9.77% | |
general and administrative expenses | 6.13M - | 5.34M 12.84% | 5.17M 3.13% | 4.96M 4.06% | 4.07M 17.97% | 4.68M 14.91% | 6.61M 41.39% | 6.51M 1.54% | 9.12M 40.00% | 10.24M 12.32% | |
selling general and administrative expenses | 9.28M - | 9.62M 3.67% | 8.62M 10.44% | 8.22M 4.57% | 6.64M 19.25% | 7.73M 16.46% | 10.86M 40.37% | 12.03M 10.83% | 15.50M 28.79% | 17.24M 11.27% | |
research and development expenses | 2.27M - | 4.84M 113.91% | 4.19M 13.44% | 4.29M 2.36% | 4.40M 2.52% | 4.80M 9.02% | 5.85M 21.99% | 7.20M 22.95% | 9.37M 30.27% | 11.54M 23.16% | |
other expenses | -1.13M - | 225K 119.93% | -38K 116.89% | -56K 47.37% | -88K 57.14% | -39K 55.68% | -42K 7.69% | 71K 269.05% | -24K 133.80% | -11K 54.17% | |
cost and expenses | 17.81M - | 22.10M 24.09% | 21.50M 2.73% | 22.22M 3.36% | 21.59M 2.81% | 26.80M 24.09% | 33.59M 25.35% | 40.70M 21.17% | 48.50M 19.16% | 58.32M 20.24% | |
operating expenses | 11.55M - | 14.47M 25.30% | 12.81M 11.45% | 12.52M 2.30% | 11.04M 11.78% | 12.53M 13.49% | 16.71M 33.33% | 19.23M 15.08% | 24.87M 29.34% | 28.79M 15.75% | |
interest expense | 39K - | 24K - | |||||||||
ebitda | -6.05M - | -13.02M 115.38% | -10.16M 21.99% | -6.64M 34.64% | -994K 85.03% | 876K 188.13% | -308K 135.16% | 1.52M 594.16% | 2.23M 46.78% | -1.40M 162.49% | |
operating income | -6.26M - | -13.24M 111.47% | -10.32M 22.07% | -6.81M 34.00% | -1.35M 80.11% | 270K 119.94% | -1.47M 643.70% | 338K 123.02% | 607K 79.59% | -4.45M 832.95% | |
depreciation and amortization | 213K - | 214K 0.47% | 156K 27.10% | 168K 7.69% | 360K 114.29% | 606K 68.33% | 1.16M 91.42% | 1.18M 2.07% | 1.63M 37.42% | 3.05M 87.65% | |
total other income expenses net | -1.13M - | 225K 119.93% | -38K 116.89% | -56K 47.37% | -88K 57.14% | -39K 55.68% | -377K 866.67% | 71K 118.83% | -24K 133.80% | -818K 3,308.33% | |
income before tax | -7.39M - | -13.01M 76.11% | -10.35M 20.43% | -6.87M 33.70% | -1.44M 78.99% | 231K 116.02% | -1.84M 898.70% | 409K 122.17% | 583K 42.54% | -5.27M 1,003.43% | |
income tax expense | 17K - | 127K 647.06% | 92K 27.56% | 19K 79.35% | 63K 231.58% | 103K 63.49% | 130K 26.21% | 75K 42.31% | 35K 53.33% | 68K 94.29% | |
net income | -7.41M - | -13.14M 77.42% | -10.45M 20.50% | -6.88M 34.10% | -1.50M 78.14% | 128K 108.50% | -1.98M 1,642.97% | 362K 118.33% | 548K 51.38% | -5.33M 1,073.54% | |
weighted average shs out | 5.57M - | 8.70M 56.17% | 8.70M 0.08% | 10.68M 22.88% | 10.99M 2.87% | 11.34M 3.18% | 11.84M 4.44% | 13.14M 10.94% | 13.20M 0.44% | 13.54M 2.61% | |
weighted average shs out dil | 5.61M - | 8.70M 55.10% | 8.70M 0.03% | 10.98M 26.16% | 11.00M 0.19% | 14.10M 28.11% | 11.84M 15.98% | 14.57M 23.05% | 14.16M 2.84% | 13.54M 4.37% | |
eps | -1.32 - | -1.51 14.39% | -1.20 20.53% | -0.63 47.50% | -0.14 77.78% | 0.01 108.07% | -0.17 1,604.42% | 0.03 116.24% | 0.04 50.36% | -0.39 1,039.76% | |
epsdiluted | -1.32 - | -1.51 14.39% | -1.20 20.53% | -0.63 47.50% | -0.14 77.78% | 0.01 106.50% | -0.17 1,968.13% | 0.02 114.59% | 0.04 56.05% | -0.39 1,107.75% |
All numbers in USD (except ratios and percentages)